IRIS UniCatt

De Pascale, Gennaro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.381
NA - Nord America 3.781
AS - Asia 1.781
SA - Sud America 411
AF - Africa 35
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 6
Totale 10.413
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.727
DE - Germania 1.216
IT - Italia 852
SE - Svezia 723
CN - Cina 671
SG - Singapore 583
BR - Brasile 341
FR - Francia 258
PL - Polonia 255
IE - Irlanda 230
UA - Ucraina 229
GB - Regno Unito 169
ID - Indonesia 113
FI - Finlandia 111
TR - Turchia 107
IN - India 84
RU - Federazione Russa 78
NL - Olanda 55
HK - Hong Kong 47
KR - Corea 46
AT - Austria 37
BE - Belgio 34
CA - Canada 31
ES - Italia 29
IR - Iran 24
AR - Argentina 23
CO - Colombia 18
VN - Vietnam 18
CH - Svizzera 17
CZ - Repubblica Ceca 17
JP - Giappone 17
MX - Messico 17
AU - Australia 16
CL - Cile 9
GR - Grecia 9
CI - Costa d'Avorio 7
EE - Estonia 7
EG - Egitto 7
LT - Lituania 7
MK - Macedonia 7
PE - Perù 7
PK - Pakistan 7
PT - Portogallo 7
VE - Venezuela 7
EU - Europa 6
IQ - Iraq 6
RO - Romania 6
TW - Taiwan 6
UZ - Uzbekistan 6
BD - Bangladesh 5
BG - Bulgaria 5
IL - Israele 5
KZ - Kazakistan 5
MA - Marocco 5
VA - Santa Sede (Città del Vaticano) 5
AE - Emirati Arabi Uniti 4
PH - Filippine 4
RS - Serbia 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
BO - Bolivia 3
CR - Costa Rica 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AM - Armenia 2
DZ - Algeria 2
EC - Ecuador 2
GT - Guatemala 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MU - Mauritius 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
CG - Congo 1
CM - Camerun 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 10.413
Salva come PNG Salva come JPEG
Città #
Chandler 713
Singapore 368
Ashburn 270
Dublin 227
Warsaw 213
Jacksonville 157
Ann Arbor 143
Rome 135
Milan 133
San Mateo 131
Nanjing 129
New York 129
The Dalles 119
Jakarta 111
Chicago 92
Wilmington 91
Nürnberg 84
Fairfield 83
Dearborn 82
Woodbridge 80
Seattle 71
Boston 65
Izmir 64
Marseille 64
Houston 61
Beijing 59
Munich 59
Cattolica 58
Helsinki 54
Los Angeles 53
Moscow 52
Redwood City 50
North Bergen 49
Nanchang 48
Hefei 46
Princeton 46
Seoul 41
Lawrence 40
Nuremberg 37
Hong Kong 36
Bremen 31
Frankfurt am Main 31
Kraków 30
Brussels 29
Kunming 29
Boardman 28
Cambridge 28
London 28
Redmond 23
Hangzhou 22
Augusta 20
Norwalk 20
Padova 20
Pune 20
Lancaster 19
São Paulo 19
Tianjin 19
Hebei 18
Mountain View 18
Kocaeli 17
Belo Horizonte 16
Shenyang 15
University Park 15
Vienna 15
Washington 15
Changsha 14
Düsseldorf 14
Falkenstein 14
Guangzhou 14
Kish 14
Jiaxing 13
Paris 13
San Diego 12
Verona 12
Brno 11
Brooklyn 11
Falls Church 11
Leawood 11
Renton 11
Shanghai 11
Toronto 11
Turin 11
Zhengzhou 11
Portsmouth 10
Santa Clara 10
Zurich 10
Buenos Aires 9
Fremont 9
Ottawa 9
Busto Arsizio 8
Jinan 8
Lauterbourg 8
Phoenix 8
Abidjan 7
Andover 7
Bogotá 7
Campinas 7
Ho Chi Minh City 7
Juiz de Fora 7
Lappeenranta 7
Totale 5.445
Salva come PNG Salva come JPEG
Nome #
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 315
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 252
Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 231
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 215
Colistin use in critically ill patients: in search of the optimal dosing. 212
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 189
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 186
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 177
Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage 175
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 172
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 155
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 151
Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study 149
Clinical and microbiological outcome in septic patients with extremely low 25-hydroxyvitamin D levels at initiation of critical care 149
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 146
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 139
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 138
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 137
Neurological involvement during legionellosis, look beyond the lung 134
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 134
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 129
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project 127
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 126
Data on the application of early coagulation support protocol in the management of major trauma patients 126
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 123
The importance of airway and lung microbiome in the critically ill 123
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 119
Acute myopathic quadriplegia in COVID-19 patients in the intensive care unit 117
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 112
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 111
Neurological involvement during Legionellosis, look beyond the lung 110
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 105
Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study 103
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 101
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 100
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 98
Why Should We Monitor (1-3)- -D-Glucan Levels during Invasive Candidiasis? Just Ask Your Ophthalmologist! 97
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 96
Sarilumab use in severe SARS-CoV-2 pneumonia 96
Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study 95
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 95
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: A randomized trial 94
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial 94
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 93
Noninvasive ventilation for the immunocompromised patient: always appropriate? 92
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 92
Lice, rodents, and many hopes: a rare disease in a young refugee 92
High Failure Rate of Noninvasive Oxygenation Strategies in Critically Ill Subjects With Acute Hypoxemic Respiratory Failure Due to COVID-19 90
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 87
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 87
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 85
Aerosolized colistin cost-effectiveness. Response 84
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 83
Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital’s Five-Month Experience 81
Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study 80
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 79
CO2driven endotracheal tube cuff control in critically ill patients: A randomized controlled study 78
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 77
Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin 77
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 77
The place of dexmedetomidine light sedation in patients with acute brain injury 75
Usefulness of differential time to positivity between catheter and peripheral blood cultures for diagnosing catheter-related bloodstream infection: Data analysis from routine clinical practice in the intensive care unit 74
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 74
The challenge of identifying resistant-organism pneumonia in the emergency department: still navigating on the erie canal? 74
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections 73
Dose of colistin: a work in progress? 72
Appropriate Tigecycline Use for Extensively Drug-Resistant Infections: The Standard Dose May Not Be Enough! 70
Fungal infections in the ICU: advances in treatment and diagnosis 69
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 69
Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation 68
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: A two-center, matched case-control study 68
Effects of thyroid hormone treatment on diaphragmatic efficiency in mechanically ventilated subjects with nonthyroidal illness syndrome 68
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 68
Response 67
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 66
Microbiologic surveillance through subglottic secretion cultures during invasive mechanical ventilation: a prospective observational study 65
Miliary tuberculosis leading to acute respiratory distress syndrome: Clinical experience in pediatric intensive care 62
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis 61
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: a randomized trial 61
Hemadsorption 61
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study 59
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study 59
Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda 59
Long-term outcome of COVID-19 patients treated with helmet noninvasive ventilation vs. high-flow nasal oxygen: a randomized trial 58
Comparable Serum and Plasma 1,3-β-D-Glucan Values Using the Wako β-Glucan Test Assay in Patients with Probable or Proven Fungal Diseases 58
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study 54
Respective Effects of Helmet Pressure Support, Continuous Positive Airway Pressure, and Nasal High-Flow in Hypoxemic Respiratory Failure: A Randomized Crossover Clinical Trial 53
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study 53
Lung Recruitability and Positive End-Expiratory Pressure Setting in ARDS Caused by COVID-19 52
Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia 51
Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies 50
Antimicrobial Exposure in Critically Ill Patients with Sepsis-Associated Multi-Organ Dysfunction Requiring Extracorporeal Organ Support: A Narrative Review 49
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 48
Cefiderocol for severe carbapenem-resistant a. Baumannii pneumonia: Towards the comprehension of its place in therapy 47
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study 47
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: A pilot study 47
How to manage aspergillosis in non-neutropenic intensive care unit patients 47
Physiological effects of awake prone position in acute hypoxemic respiratory failure 46
Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study 45
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 44
Totale 9.878
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.863
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.863
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202067 0 0 0 0 0 0 0 0 0 0 0 67
2020/2021808 39 69 23 55 82 65 103 32 99 54 137 50
2021/20221.104 90 73 67 69 85 58 24 166 59 72 164 177
2022/20232.154 230 268 137 296 145 236 107 204 248 109 110 64
2023/20241.365 79 280 64 60 67 201 100 96 42 78 145 153
2024/20252.394 80 69 202 129 187 113 179 137 434 277 534 53
Totale 10.587